Merck, the US pharmaceutical group, said it would cut its global workforce by more than 10 per cent as it slashed full-year profit forecasts and reported a 28 per cent slump in third-quarter earnings.

The company’s shares fell almost 4 per cent to $28.89 in early afternoon trading.